Literature DB >> 15317965

The HAQ disability index in scleroderma trials.

S R Johnson, P Lee.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15317965     DOI： 10.1093/rheumatology/keh288

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat's technique and kinesitherapy: a randomized controlled trial.

Authors:  S Maddali-Bongi; G Landi; F Galluccio; A Del Rosso; I Miniati; M L Conforti; R Casale; M Matucci-Cerinic
Journal:  Rheumatol Int       Date:  2010-03-18       Impact factor: 2.631

2.  Low vitamin D status in systemic sclerosis and the impact on disease phenotype.

Authors:  Laura Groseanu; Violeta Bojinca; Tania Gudu; Ioana Saulescu; Denisa Predeteanu; Andra Balanescu; Florian Berghea; Daniela Opris; Andreea Borangiu; Cosmin Constantinescu; Magda Negru; Ruxandra Ionescu
Journal:  Eur J Rheumatol       Date:  2016-02-01

3.  Clinical Phenotype of Endothelial Dysfunction in Romanian Scleroderma Patients.

Authors:  Laura Groseanu; Florian Berghea; Andra Balanescu; Denisa Predeteanu; Violeta Bojinca; Ioana Saulescu; Cosmin Constantinescu; Daniela Opris; Mihai Abobului; Andreea Borangiu; Maria-Magdalena Negru; Violeta Vlad; Ruxandra Ionescu
Journal:  Maedica (Bucur)       Date:  2016-03

4.  Clinical Phenotype of Endothelial Dysfunction in a Lot of Romanian Scleroderma Patients.

Authors:  Laura Groseanu; Florian Berghea; Andra Balanescu; Denisa Predeteanu; Violeta Bojinca; Ioana Saulescu; Cosmin Constantinescu; Daniela Opris; Mihai Abobului; Andreea Borangiu; Maria-Magdalena Negru; Violeta Vlad; Ruxandra Ionescu
Journal:  Maedica (Bucur)       Date:  2015-09

5.  Development and evaluation of a crosswalk between the SF-36 physical functioning scale and Health Assessment Questionnaire disability index in rheumatoid arthritis.

Authors:  Peter M ten Klooster; Martijn A H Oude Voshaar; Barbara Gandek; Matthias Rose; Jakob B Bjorner; Erik Taal; Cees A W Glas; Piet L C M van Riel; Mart A F J van de Laar
Journal:  Health Qual Life Outcomes       Date:  2013-11-15       Impact factor: 3.186
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.